Hologi announced that Nanaz Mohtashami has been elected to the Company’s Board of Directors, effective September 20, 2023. Mohtashami was also appointed to the Compensation Committee and the Nominating and Corporate Governance Committee effective September 20, 2023. Mohtashami is a Managing Director at Russell Reynolds Associates, a leading executive search and leadership advisory firm, where she heads their global Med Tech, Devices & Diagnostics Practice.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on HOLX:
- Hologic, Bayer team to bring contrast-enhanced mammography package to facilities
- Hologic price target lowered to $85 from $87 at RBC Capital
- Hologic price target lowered to $86 from $94 at BofA
- Hologic narrows FY23 EPS view to $3.87-$3.94 from $3.75-$3.95, consensus $3.91
- Hologic sees Q4 adjusted EPS 80c-87c, consensus 87c